Want to create an interactive transcript for this episode?
Podcast: DirectorsTalk Interviews
Episode: Avacta Group CEO Alastair Smith Rapid COVID19 Test Strips Available Summer
Description: Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss the development and manufacture of a rapid test for the COVID-19 coronavirus infection for population screening. Alastair explains what the test will be able to do, why the Affimer platform is ideal for developing this kind of diagnostic, the commercial terms of the agreement and when we should expect the test to be available.Avacta Group is developing novel cancer immunotherapies combining its two proprietary platforms – Affimer® biotherapeutics and pre|CISION™ tumour targeted chemotherapy. With this approach, the Company aims to address the l...